Potent Nonpeptide Antagonists of the Bradykinin B1 Receptor:  Structure−Activity Relationship Studies with Novel Diaminochroman Carboxamides

Author:

Biswas Kaustav1,Li Aiwen1,Chen Jian Jeffrey1,D'Amico Derin C.1,Fotsch Christopher1,Han Nianhe1,Human Jason1,Liu Qingyian1,Norman Mark H.1,Riahi Bobby1,Yuan Chester1,Suzuki Hideo1,Mareska David A.1,Zhan James1,Clarke David E.1,Toro Andras1,Groneberg Robert D.1,Burgess Laurence E.1,Lester-Zeiner Dianna1,Biddlecome Gloria1,Manning Barton H.1,Arik Leyla1,Dong Hong1,Huang Ming1,Kamassah Augustus1,Loeloff Richard1,Sun Hong1,Hsieh Feng-Yin1,Kumar Gondi1,Ng Gordon Y.1,Hungate Randall W.1,Askew Benny C.1,Johnson Eileen1

Affiliation:

1. Departments of Chemistry Research and Discovery, Pharmacokinetics and Drug Metabolism, Neuroscience, and Inflammation, Amgen Inc., One Amgen Center Drive, Thousand Oaks, California 91320, and Array BioPharma, 3200 Walnut Street, Boulder, Colorado 80301

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Cited by 24 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3